Armistice Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $7.08 Billion distributed in 232 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $288M, Supernus Pharmaceuticals, Inc. with a value of $175M, Travere Therapeutics, Inc. with a value of $128M, Neurocrine Biosciences Inc with a value of $122M, and Incyte Corp with a value of $122M.
Examining the 13F form we can see an increase of $1.06B in the current position value, from $6.02B to 7.08B.
Armistice Capital, LLC is based out at New York, NY
Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$7.08 Billion
ETFs: $2.97 Billion
Healthcare: $2.74 Billion
Consumer Cyclical: $455 Million
Consumer Defensive: $393 Million
Technology: $383 Million
Communication Services: $45.7 Million
Industrials: $34.5 Million
Basic Materials: $27.5 Million
Other: $24.9 Million
Stock Holdings Table Market Cap. of $2 Billions to $10 Billions
